• Lifestyle
More

    HIV vaccine efficacy study begins in South Africa

    Must Read

    Covid 19 cases reached 10688 in Vadodara after 129 new cases on Monday

    Total 109 discharged from hospital taking the total to 9010 Covid 19 cases in...

    Jio Cricket Play Along begins with cricket season

    The award-winning Jio Cricket Play Along (JCPA) has begun with the cricket season. This time, JCPA brings...

    Shraddha Kapoor, Sara Ali Khan may be summoned in drugs case: Sources

    Actors Shraddha Kapoor and Sara Ali Khan may be called for questioning this week in the widening...

    The first HIV vaccine efficacy study in seven years has begun in South Africa to test whether a modified vaccine candidate can provide effective protection against the AIDS virus, the US National Institutes of Health said.

    The study — called HVTN 702 — aims to enroll 5,400 sexually active men and women aged 18 to 35 years, making it the largest and most advanced HIV vaccine clinical trial to take place in South Africa,

    “If deployed alongside our current armoury of proven HIV prevention tools, a safe and effective vaccine could be the final nail in the coffin for HIV,” said Director of the National Institute of Allergy and Infectious Diseases (NIAID), Anthony Fauci in a statement.

    The experimental vaccine regimen being tested in HVTN 702 is based on the one investigated in the RV144 clinical trial in Thailand that was found to be 31.2 per cent effective at preventing HIV infection over the 3.5-year follow-up after vaccination.

    The new trial, to be conducted at 15 sites across South Africa, where more than 1,000 people become infected with HIV every day, aims to test whether it will provide greater and more sustained protection than the RV144 regimen.

    Volunteers will been randomly assigned to receive either the investigational vaccine regimen or a placebo. All participants will receive a total of five injections over one year, and results are expected in late 2020.

    “If an HIV vaccine were found to work in South Africa, it could dramatically alter the course of the pandemic,” said HVTN 702 Protocol Chair and President of the South African Medical Research Council Glenda Gray.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Jio Cricket Play Along begins with cricket season

    The award-winning Jio Cricket Play Along (JCPA) has begun with the cricket season. This time, JCPA brings...

    Jio Cricket Play Along begins with cricket season

    The award-winning Jio Cricket Play Along (JCPA) has begun with the cricket season. This time, JCPA brings a new engaging and experience...

    Shraddha Kapoor, Sara Ali Khan may be summoned in drugs case: Sources

    Actors Shraddha Kapoor and Sara Ali Khan may be called for questioning this week in the widening drugs probe linked to actor...

    Charusat student bagged annual Package of 30 Lakhs

    The COVID-19 crisis has adversely affected the world economy. The impact was mainly felt on the employment front where several people felt...

    Women officers in helicopter stream of Indian Navy

    In yet another first in the history of Indian naval aviation, two women officers have been selected to join as “Observers” (Airborne...

    More Articles Like This

    - Advertisement -